Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;38(2):101964.
doi: 10.1016/j.berh.2024.101964. Epub 2024 Jun 19.

CARD9 in the pathogenesis of axial spondyloarthritis

Affiliations
Review

CARD9 in the pathogenesis of axial spondyloarthritis

A L Seufert et al. Best Pract Res Clin Rheumatol. 2024 May.

Abstract

Axial spondyloarthritis (axSpA) has been long classified as an autoimmune disease caused by a breakdown in the ability of the immune system to delineate self from foreign, resulting in self-reactive T cells. The strong genetic association of HLA-B27 supports this role for T cells. More recently, genetic and clinical studies indicate a prominent role of the environment in triggering axSpA, including an important role for microbes and the innate immune response. As an example, mutations in genes associated with innate immunity, including the anti-fungal signaling molecule Caspase recruitment domain-containing protein 9 (CARD9), have been linked to axSpA susceptibility. Thus, current thought classifies axSpA as a "mixed pattern condition" caused by both autoimmune and autoinflammatory mechanisms. The goal of this review is to convey.

Keywords: Ankylosing spondylitis; Axial spondyloarthritis; CARD9 protein; Neutrophils; Spondyloarthritis.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest There are no conflict of interest for co-authors AS, HS, LC, or RN.

Figures

Fig. 1.
Fig. 1.. Overview of the pathogenesis of axSpA.
Genetic and clinical studies indicate a role for both the environment and genetic factors in axSpA pathogenesis. This interaction leads to the development of pathogenic T cells that recognize self-antigens (i.e., self-reactive T cells), pro-inflammatory cytokines, and hyper-innate immune responses that cumulatively contribute to inflammation and damage of the spine and other associated tissues.
Fig. 2.
Fig. 2.. Neutrophil-intrinsic CARD9 in fungal infection and sterile inflammation.
Diagram summarizing the known effects of external environmental factors on the function of CARD9-sufficient and CARD9-deficient neutrophils. Immune functions downstream neutrophil-mediated immune responses are detailed following exposure to fungal pathogens (i.e., fungal infection [top panel]) or antibodies bound to antigen (i.e., immune complexes [middle panel]). The bottom panel shows how currently unknown environmental triggers may control neutrophils expressing the CARD9 S12N SNP to promote: disease and IL-17 production in axSpA, IBD, and experimental allergy.
Fig. 3.
Fig. 3.. Hypothetical role for CARD9S12N SNP in axSpA pathogenesis.
We hypothesize that fungal exposure of patients with underlying genetic predisposition to axSpA (e.g., co-expression of HLA-B27 and CARD9S12N SNP) may lead to the generation of pathogenic immune responses including self-reactive T cells and CARD9-activated inflammatory neutrophils. Downstream of these affects we further propose that an interaction between the self-reactive T cells and CARD9-activated neutrophils would result in development of pathogenic Th17 cells that produce IL-17A and target the enthesis and spine to promote disease in axSpA.

References

    1. Nelson DA, Kaplan RM, Kurina LM, Weisman MH. Incidence of ankylosing spondylitis among male and female United States army personnel. Arthritis Care Res Feb. 2023;75(2):332–9. 10.1002/acr.24774. - DOI - PubMed
    1. van der Heijde D, et al. Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature. Ann Rheum Dis May 2024;83(5):547–9. 10.1136/ard-2023-225185. - DOI - PubMed
    1. Sieper J, Braun J, Dougados M, Baeten D. Axial spondyloarthritis. Nat Rev Dis Prim Jul. 2015;1(1):1–16. 10.1038/nrdp.2015.13. - DOI - PubMed
    1. de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther 2016;18(1):196. 10.1186/s13075-016-1093-z. - DOI - PMC - PubMed
    1. Moltó A, et al. Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis Jun. 2016;75(6):1016–23. 10.1136/annrheumdis-2015-208174. - DOI - PubMed

Publication types

MeSH terms